New insights into antidiabetic drugs: Possible applications in cancer treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New insights into antidiabetic drugs: Possible applications in cancer treatment

Published:2017-07-23 Issue:6 Volume:90 Page:1056-1066
ISSN:1747-0277
Container-title:Chemical Biology & Drug Design
language:en
Short-container-title:Chem Biol Drug Des

Author:

Shafiei-Irannejad Vahid¹²,Samadi Nasser²,Salehi Roya³,Yousefi Bahman²,Zarghami Nosratollah¹²⁴^ORCID

Affiliation:

1. Stem Cell Research Center; Tabriz University of Medical Sciences; Tabriz Iran

2. Department of Clinical Biochemistry and Laboratory Medicine; Faculty of Medicine; Tabriz University of Medical Sciences; Tabriz Iran

3. Department of Medical Nanotechnology; Faculty of Advanced Medical Sciences; Tabriz University of Medical Sciences; Tabriz Iran

4. Department of Medical Biotechnology; Faculty of Advanced Medical Sciences; Tabriz University of Medical Sciences; Tabriz Iran

Funder

Tabriz University of Medical Sciences

Publisher

Wiley

Subject

Molecular Medicine,Biochemistry,Drug Discovery,Pharmacology,Organic Chemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cbdd.13013/fullpdf

Reference129 articles.

1. Cancer treatment and survivorship statistics, 2012

2. BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER

3. Multidrug resistance (MDR) in cancer

4. Curcumin and Silibinin Inhibit Telomerase Expression in T47D Human Breast Cancer Cells

5. Inhibition of leptin gene expression and secretion by silibinin: possible role of estrogen receptors

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diabetes and Cancer: A Twisted Bond;Oncology Reviews;2024-05-21

2. Role of SGLT2 Inhibitors, DPP-4 Inhibitors, and Metformin in Pancreatic Cancer Prevention;Cancers;2024-03-28

3. Therapeutic Repurposing of Antidiabetic Drugs in Diabetes-associated Comorbidities;Current Drug Therapy;2024-03

4. Metabolic Reprogramming of Anti-cancer T Cells: Targeting AMPK and PPAR to Optimize Cancer Immunotherapy;Indian Journal of Clinical Biochemistry;2024-01-08

5. GLP-1 receptor agonist liraglutide inhibits the proliferation and migration of thyroid cancer cells;Cellular and Molecular Biology;2023-12-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3